Stability of Asthma Control Implies No Changes in microRNAs Expression

J Investig Allergol Clin Immunol. 2019;29(5):388-389. doi: 10.18176/jiaci.0410. Epub 2019 May 7.

Authors

M J Rial^{1

2}, J M Rodrigo Muñoz^{3

2}, B Sastre^{3

2}, J Sastre^{1

2}, V Del Pozo^{3

2}

Affiliations

¹ Department of Allergy, Hospital Universitario Fundación Jimenez Diaz, Instituto de Investigación Sanitaria Fundacion Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain.
² CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Spain.
³ Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario Fundacion Jimenez Diaz. (IIS-FJD, UAM), Madrid, Spain.

PMID: 31062689
DOI: 10.18176/jiaci.0410

No abstract available

Keywords: Asthma; Biomarkers; Eosinophils; Exosomes; miRNA.

MeSH terms

Anti-Asthmatic Agents / administration & dosage
Anti-Asthmatic Agents / adverse effects
Anti-Asthmatic Agents / therapeutic use*
Asthma / diagnosis
Asthma / drug therapy*
Asthma / genetics*
Biomarkers
Circulating MicroRNA / blood
Gene Expression Regulation / drug effects*
Humans
MicroRNAs / blood
MicroRNAs / genetics*
Respiratory Function Tests

Substances

Anti-Asthmatic Agents
Biomarkers
Circulating MicroRNA
MicroRNAs